Based on the fact that multiple studies have shown the anti-tumor effect of Nox4 targeting approaches in established tumors (62,63), including breast cancers (64,65), in addition to the evidence presented in the present study, we strongly believe that Nox4 remains a promising CAF target for solid tumors and its role in breast cancer warrants more studies. Here, NOX4 is linked to breast cancer.